Literature DB >> 3081662

Adherence of platelets to human endothelial cells infected by Rickettsia rickettsii.

D J Silverman.   

Abstract

Rickettsia rickettsii, the etiologic agent of Rocky Mountain spotted fever, causes widespread vasculitis due to extensive injury of endothelial cells lining small blood vessels. Injury to these cells can lead to denudation of the endothelial lining and exposure of the thrombogenic subendothelium. Modification of the cell surface, either through minor trauma or as a result of altered cell surface biochemistry, could induce changes reflected in increased platelet reactivity. Because membrane modification is likely when R. rickettsii enters endothelial cells, the possibility that infection by this organism caused increased reactivity of platelets with the endothelial cell surface was examined. A fourfold increase in adherence of platelets to cultured endothelial cells from the human umbilical vein infected by R. rickettsii compared with uninfected cells was found. These studies suggest that the adherence of platelets to the surface of Rickettsia-infected endothelial cells can contribute to reduction in the number of circulating platelets in blood during human infection.

Entities:  

Mesh:

Year:  1986        PMID: 3081662     DOI: 10.1093/infdis/153.4.694

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity.

Authors:  Suresh G Joshi; Charles W Francis; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection.

Authors:  D R Clifton; R A Goss; S K Sahni; D van Antwerp; R B Baggs; V J Marder; D J Silverman; L A Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.

Authors:  L A Sporn; S K Sahni; N B Lerner; V J Marder; D J Silverman; L C Turpin; A L Schwab
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells.

Authors:  M Drancourt; M C Alessi; P Y Levy; I Juhan-Vague; D Raoult
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

6.  Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii.

Authors:  S K Sahni; D J Van Antwerp; M E Eremeeva; D J Silverman; V J Marder; L A Sporn
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Pulmonary embolism complicating murine typhus.

Authors:  I Potasman; H M Bassan
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

8.  Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation.

Authors:  L A Sporn; V J Marder
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells.

Authors:  N Teysseire; D Arnoux; F George; J Sampol; D Raoult
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 10.  Host-cell interactions with pathogenic Rickettsia species.

Authors:  Sanjeev K Sahni; Elena Rydkina
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.